Conroy Kevin T. - 17 Mar 2022 Form 4 Insider Report for EXACT SCIENCES CORP (EXAS)

Role
President and CEO, Director
Signature
/s/ Kevin T. Conroy by Mark R. Busch, attorney-in-fact
Issuer symbol
EXAS
Transactions as of
17 Mar 2022
Net transactions value
+$1,509,569
Form type
4
Filing time
18 Mar 2022, 16:22:01 UTC
Previous filing
02 Mar 2022
Next filing
01 Apr 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction EXAS Common Stock Options Exercise $1,309,615 +229,757 +25% $5.70* 1,160,741 17 Mar 2022 Direct F1
transaction EXAS Common Stock Options Exercise $99,988 +4,612 +0.4% $21.68 1,165,353 17 Mar 2022 Direct F1
transaction EXAS Common Stock Options Exercise $99,966 +2,253 +0.19% $44.37 1,167,606 17 Mar 2022 Direct F1, F2
holding EXAS Common Stock 26,584 17 Mar 2022 Held in 401(k) Plan
holding EXAS Common Stock 21,730 17 Mar 2022 Held in Grantor Retained Annuity Trust
holding EXAS Common Stock 21,730 17 Mar 2022 Held in Grantor Retained Annuity Trust
holding EXAS Common Stock 21,729 17 Mar 2022 Held in Grantor Retained Annuity Trust

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction EXAS Stock Option (right to buy) Options Exercise $0 -229,757 -100% $0.000000* 0 17 Mar 2022 Common Stock 229,757 $5.70 Direct F3
transaction EXAS Stock Option (right to buy) Options Exercise $0 -4,612 -1.9% $0.000000 235,388 17 Mar 2022 Common Stock 4,612 $21.68 Direct F4
transaction EXAS Stock Option (right to buy) Options Exercise $0 -2,253 -3.3% $0.000000 66,047 17 Mar 2022 Common Stock 2,253 $44.37 Direct F5
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents shares of Common Stock acquired upon the exercise of options in an exercise-and-hold transaction.
F2 In addition to the shares of Common Stock reported on this Form 4, which total 1,259,379 shares, Mr. Conroy also holds, in the aggregate, an additional 761,441 vested and unvested options to purchase shares of Common Stock and restricted stock units, with each restricted stock unit representing a contingent right to receive one share of Common Stock.
F3 These options vested in full on February 26, 2020.
F4 These options vested in full on February 23, 2021.
F5 These options vested in full on February 27, 2022.